Ranbaxy
HC blocks Ranbaxy-Sun Pharma merger over insider trading allegations
30 Apr 2014
The order was in response to a petition for a Sebi inquiry into possible insider trading in Ranbaxy shares that saw heavy trading before the merger with Sun Pharma was announced
Ranbaxy drug flows to Europe, US to dry up
09 Apr 2014
Sun Pharmaceutical Industries plans to phase out sales of Ranbaxy’s branded generic drugs in the US while continuing sales in other markets
Sun Pharma, Ranbaxy to merge in Rs24,000 all-stock deal
07 Apr 2014
The merger will create India's largest pharmaceutical company and the world's fifth largest speciality generics company with annual emerging market sales nearing Rs6,000 crore
Shocking dosage mix-up forces Ranbaxy to recall generic Liptor in US
08 Mar 2014
Quality concerns about India's $14 billion drug industry have come to the fore after the US FDA banned plants run by Ranbaxy and Wockhardt Ltd from sending drugs to the US, for failure to meet manufacturing standards
.webp)
